New Study Explores Immune System Stimulation In Battle Against HER-2/neu Positive Breast Cancer

The Mayo Clinic is excited to announce a Phase I study of a new therapeutic vaccine in HER-2/neu positive breast cancer patients in the fourth quarter of 2011. To understand the importance of this development, the HER-2/neu and the significance of HER-2/neu positive breast cancer must be examined…

Flaxseed No Cure For Hot Flashes During Breast Cancer Or Menopause

ASCO Abstract #CRA9015: Flaxseed provides no benefit in easing hot flashes among breast cancer patients and postmenopausal women, according to a Mayo Clinic and North Central Cancer Treatment Group (NCCTG) study…

Microbiomes May Hold Key To Better Understanding Of Preterm Birth

A team of scientists from Mayo Clinic, the University of Illinois at Urbana-Champaign, and the J. Craig Venter Institute are leveraging a long-standing research relationship to apply results from the Human Microbiome Project to help identify microbial risk predictors for preterm birth…

Medical Edge: Hormone changes play a role in development of migraine headaches

DEAR MAYO CLINIC: I’m a 40yearold woman, and last month I experienced my first migraine headache. Friends have told me that because I’ve had one migraine, I’ll likely get more as I get older, until I reach menopause. Is that true? If so, what can I do to reduce my risk?

Robotic Repair For Vaginal Prolapse Has Significant Benefits, Mayo Researchers Find

New Mayo Clinic research has found that robotic surgery for vaginal prolapse (http://www.mayoclinic.org/pelvic-organ-prolapse/) dramatically reduces patient hospital stay and recovery time. These findings are being presented this week at the North Central Section of the American Urological Association in Scottsdale, Ariz.

« Previous Page